Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
